Researchers at Western University and Lawson Health Research Institute are using tobacco plants as ‘green bioreactors’ to produce an anti-inflammatory protein with powerful therapeutic potential.
The plants are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing potential for treating a number of inflammatory and autoimmune disorders like type 2 diabetes, stroke, dementia and arthritis.
“This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases,” said Dr. Tony Jevnikar, Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson. “The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury.”
And while showing promise in animal models, IL-37’s use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.
That’s where the tobacco plants come in.
This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. “The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods,” said Shengwu Ma, PhD, Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. “Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks.”
The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they’ve shown they can produce the protein in tobacco, it can be translated to other plants, like potatoes.
Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.
“I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable,” Dr. Jevnikar said.
The Latest on: Green bioreactors
via Google News
The Latest on: Green bioreactors
- Op-Ed: Wastewater recycling got derailed in Los Angeles. Now it’s back on trackon May 17, 2021 at 3:00 am
But during the primary he alarmed voters across the city by insisting that Los Angeles was furtively planning to pipe recycled sewage to millions of unsuspecting Angelenos — without, according to ...
- Lab-Made Chicken Reaches Select Diners in Singaporeon May 14, 2021 at 5:00 am
Singapore regulators in December approved in vitro cultured chicken, giving the world’s lab-developed meat industry its official commercial start. The company behind the poultry product, Eat Just, has ...
- ‘Clean meat as a service’: Plug-and-play tech turns meat producers into cell-based pork producerson May 13, 2021 at 8:39 am
German start-up Innocent Meat is developing plug-and-play technology that allows conventional meat processors to produce cultivated pork. We catch up with co-founder and CEO Laura Gertenbach to find ...
- Explained: The debate over vaccine GST exemptionon May 13, 2021 at 1:55 am
Some experts feel categorising domestic supplies as zero-rated might be a better option than granting a full exemption, since it will pave the way for availing input tax credit.
- Whole Foods Founder Mackey Invests in Producer of Cultured Meaton May 12, 2021 at 3:00 am
A prominent producer of cultivated meat is renaming itself and announcing its first commercial plans -- and has secured investment from Whole Foods Market and its founder, John Mackey.
- Raising Awareness of 4.0 in Biomanufacturing—Part IIon May 4, 2021 at 12:00 pm
Adopting 4.0 in one suite at one site may cost tens of thousands of dollars, but it’s important to keep in mind that plant-wide deployment or implementation at ten facilities will cost millions.
- Scientists Make Microplastics Breakthrough, Devising Method to Trap And Remove Themon April 29, 2021 at 7:23 am
Microbiologists have found a way to use bacteria to trap microplastics, removing them from the environment and making them easier to recycle. The new technique, developed by scientists at Hong Kong ...
- Laser Projectors Market Size, Share, Industry Demand, Global Opportunity Analysis, Industry Growth, Forecast To 2027on April 27, 2021 at 11:00 pm
Generally one or three laser sources red, green and blue are used, combination of these laser beams creates image or video pattern on screen. The Laser Projectors Market sample report includes an ...
- The ‘green’ milk made from cellson August 25, 2020 at 11:05 am
To improve the dairy industry’s green credentials ... cells in our lab and encouraging them to produce milk in giant bioreactors. The cells stick to tiny straws, the a fluid is then drawn ...
- Useful and non-pollutingon August 9, 2020 at 5:14 am
Its production process begins by growing bacteria of the species Alcaligenes eutrophus in bioreactors in which they are fed cane ... which could result in a green and self-sustainable process,” she ...
via Bing News